Charles Schwab Investment Management Inc. Has $27.29 Million Stock Holdings in Select Medical Holdings Corporation $SEM

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Select Medical Holdings Corporation by 1.4%, holding approximately 1.27% of the company, valued at $27.29 million after selling 22,443 shares.
• Analysts have adjusted their price targets for Select Medical, with Royal Bank of Canada lowering it from $23.00 to $19.00 and UBS Group reducing it from $15.00 to $14.00, while overall consensus remains a "Moderate Buy" with a price target of $20.25.
• Select Medical recently initiated a $1 billion share buyback plan, indicating the board’s belief that the company’s shares are undervalued, and also announced a quarterly dividend of $0.0625 per share.

Charles Schwab Investment Management Inc. decreased its stake in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 1.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,633,877 shares of the health services provider's stock after selling 22,443 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.27% of Select Medical worth $27,286,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC increased its position in shares of Select Medical by 151.0% during the 1st quarter. SG Americas Securities LLC now owns 37,684 shares of the health services provider's stock worth $629,000 after purchasing an additional 22,671 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Select Medical by 47.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 24,450 shares of the health services provider's stock worth $403,000 after acquiring an additional 7,871 shares during the period. Janney Montgomery Scott LLC bought a new position in shares of Select Medical during the 1st quarter worth approximately $416,000. GAMMA Investing LLC boosted its stake in shares of Select Medical by 217.4% during the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after acquiring an additional 4,453 shares during the period. Finally, Ritholtz Wealth Management bought a new position in shares of Select Medical during the 1st quarter worth approximately $460,000. Institutional investors and hedge funds own 89.48% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on SEM shares. Royal Bank Of Canada reduced their target price on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research note on Wednesday, May 7th. UBS Group reiterated a "neutral" rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $20.25.

Select Medical Stock Performance

SEM traded up $0.4150 during trading on Friday, hitting $13.4050. The stock had a trading volume of 985,317 shares, compared to its average volume of 1,267,498. The company has a 50 day moving average price of $14.04 and a 200-day moving average price of $15.74. The firm has a market cap of $1.66 billion, a price-to-earnings ratio of 12.65, a P/E/G ratio of 0.69 and a beta of 1.25. Select Medical Holdings Corporation has a one year low of $11.65 and a one year high of $40.98. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The firm's quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, research analysts predict that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th will be issued a $0.0625 dividend. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.25 annualized dividend and a yield of 1.9%. Select Medical's payout ratio is currently 23.58%.

Select Medical declared that its Board of Directors has authorized a stock buyback plan on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the health services provider to repurchase up to 42.6% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.